Clinical Department of Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium.
Department of Cardiovascular Sciences, KU Leuven, Leuven Belgium.
Clin Chem Lab Med. 2021 Jan 15;59(6):1047-1061. doi: 10.1515/cclm-2020-1859. Print 2021 May 26.
The International Organization for Standardization (ISO) 15189:2012 standard aims to improve quality in medical laboratories through standardization of all key elements in the total testing process, including the pre-analytical phase. It is hence essential that accreditation bodies, assessing laboratories against ISO15189:2012, pay sufficient attention to auditing pre-analytical activities. However, there are significant differences in how technical auditors interpret the pre-analytical requirements described in ISO15189:2012. In this consensus document, the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for Pre-analytical Phase (WG-PRE) sets out to review pre-analytical requirements contained in ISO15189:2012 and provide guidance for laboratories on how to meet these requirements. The target audience for this consensus document is laboratory professionals who wish to improve the quality of the pre-analytical phase in their laboratory. For each of the ISO requirements described in ISO15189:2012, members of EFLM WG-PRE agreed by consensus on minimal recommendations and best-in-class solutions. The minimal consensus recommendation was defined as the minimal specification which laboratories should implement in their quality management system to adequately address the pre-analytical requirement described in ISO15189:2012. The best-in-class solution describes the current state-of-the-art in fulfilling a particular pre-analytical requirement in ISO15189:2012. We fully acknowledge that not every laboratory has the means to implement these best-in-class solutions, but we hope to challenge laboratories in critically evaluating and improving their current procedures by providing this expanded guidance.
国际标准化组织(ISO)15189:2012 标准旨在通过标准化整个测试过程的所有关键要素,包括分析前阶段,来提高医学实验室的质量。因此,评估实验室是否符合 ISO15189:2012 标准的认证机构必须充分关注分析前活动的审核。然而,技术审核员对 ISO15189:2012 中描述的分析前要求的解释存在显著差异。在这份共识文件中,欧洲临床化学和实验室医学联合会(EFLM)分析前阶段工作组(WG-PRE)旨在审查 ISO15189:2012 中包含的分析前要求,并为实验室提供如何满足这些要求的指导。本共识文件的目标受众是希望提高实验室分析前阶段质量的实验室专业人员。对于 ISO15189:2012 中描述的每个 ISO 要求,EFLM WG-PRE 的成员都通过共识达成了最低建议和最佳实践解决方案。最低共识建议被定义为实验室应在其质量管理体系中实施的最低规范,以充分满足 ISO15189:2012 中描述的分析前要求。最佳实践解决方案描述了在 ISO15189:2012 中满足特定分析前要求的当前最先进水平。我们完全承认并非每个实验室都有实施这些最佳实践解决方案的手段,但我们希望通过提供这种扩展指导,挑战实验室批判性地评估和改进其当前程序。